Xtandi - enzalutamide
Navigation: NDC > Supplier starting with: A > ASTELLAS PHARMA US, INC.| Field | Value |
|---|---|
| NDC Code: | 0469-0125 |
| Proprietary Name: | Xtandi |
| Suffix: | |
| Non-Proprietary Name: | enzalutamide |
| Dosage Form: | CAPSULE |
| Method: | ORAL |
| Original Marketing Date: | 31-08-2012 |
| Category Name: | NDA |
| Application Number: | NDA203415 |
| Labeler: | ASTELLAS PHARMA US, INC. |
| Substance Name: | ENZALUTAMIDE |
| Active Numerator Strength: | 40 |
| Active Ingredient Unit: | mg/1 |
| Pharm Classes: | Androgen Receptor Inhibitor [EPC],Androgen Receptor Antagonists [MoA],Cytochrome P450 3A4 Inducers [MoA],Cytochrome P450 2C9 Inducers [MoA],Cytochrome P450 2C19 Inducers [MoA] |
| DEA Schedule: |